Mechanistic insights into vascular calcification in CKD

Journal of the American Society of Nephrology

Volumn 24, Issue 2, 2013, Pages 179-189

  Shroff, Rukshana ^a   Long, David A ^a   Shanahan, Catherine ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; BLOCKING AGENT; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; FETUIN A; FIBROBLAST GROWTH FACTOR 23; OSTEOCALCIN; OSTEOPONTIN; PHOSPHATE; PHOSPHATE TRANSPORTER; PHOSPHATIDYLSERINE; SODIUM PHOSPHATE COTRANSPORTER; SODIUM PHOSPHATE COTRANSPORTER 1; SODIUM PHOSPHATE COTRANSPORTER 2; VASCULOTROPIN A;

APOPTOSIS; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CALCIUM TRANSPORT; CARDIOVASCULAR RISK; CARTILAGE CELL; CELL DIFFERENTIATION; CHRONIC KIDNEY DISEASE; DISEASE COURSE; DYSLIPIDEMIA; EX VIVO STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC HEART DISEASE; OSSIFICATION; OSTEOBLAST; PHOSPHATE TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENESCENCE; SMOKING; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 84873350580     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011121191     Document Type: Review

References (110)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl JMed 351:1296-1305, 2004
2. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483, 2000
3. McCullough PA, Sandberg KR, Dumler F, Yanez JE: Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: A systematic review. J Nephrol 17:205-215, 2004
4. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L, Shanahan CM: Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118:1748-1757, 2008
5. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 [Suppl 3]: S112-S119, 1998
6. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31:607-617, 1998
7. Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK: Mortality risk for dialysis patients with different levels of serumcalcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52:519-530, 2008
8. Shroff RC, McNair R, Skepper JN, Figg N, Schurgers LJ, Deanfield J, Rees L, Shanahan CM: Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 21:103-112, 2010
9. Demer LL, Tintut Y: Vascular calcification: Pathobiology of a multifaceted disease. Circulation 117:2938-2948, 2008
10. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME: Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: Evidence for smooth muscle cellmediated vascular calcification. Circulation 100:2168-2176, 1999
11. Monckeberg JG: Über die reine Mediaverkalkung der Extremitä tenarterien und ihr Verhalten zur Arteriosklerose. Virchows Arch Pathol Anat 171:141-167, 1903
12. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434-2439, 1999
13. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731-1740, 2003
14. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357-366, 2003
15. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS: Osteoprotegerindeficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268, 1998
16. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage inmice lacking matrix GLA protein. Nature 386:78-81, 1997
17. Demer LL, Tintut Y: Pitting phosphate transport inhibitors against vascular calcification. Circ Res 98:857-859, 2006
18. Giachelli CM: Vascular calcification: In vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 14 [Suppl 4]: S300-S304, 2003
19. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL: Apoptosis regulates human vascular calcification in vitro: Evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 87:1055-1062, 2000
20. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM: Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857-2867, 2004
21. Reynolds JL, Skepper JN, McNair R, Kasama T, Gupta K, Weissberg PL, Jahnen-Dechent W, Shanahan CM: Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16:2920-2930, 2005
22. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan CM: Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 23:489-494, 2003
23. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC: Phosphateinduced vascular calcification: Role of pyrophosphate and osteopontin. J Am Soc Nephrol 15:1392-1401, 2004
24. Lomashvili KA, Garg P, Narisawa S, Millan JL, O'Neill WC: Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: Potentialmechanismfor uremic vascular calcification. Kidney Int 73:1024-1030, 2008
25. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL: High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393-2402, 1994
26. Hsu HH, Camacho NP: Isolation of calcifiable vesicles from human atherosclerotic aortas. Atherosclerosis 143:353-362, 1999
27. Kapustin AN, Davies JD, Reynolds JL, McNair R, Jones GT, Sidibe A, Schurgers LJ, Skepper JN, Proudfoot D, Mayr M, Shanahan CM: Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhancemineralization. Circ Res 109:e1-e12, 2011
28. Genge BR, Wu LN, Wuthier RE: In vitro modeling of matrix vesicle nucleation: Synergistic stimulation of mineral formation by annexin A5 and phosphatidylserine. J Biol Chem 282:26035-26045, 2007
29. Duer MJ, Frisciæ T, Proudfoot D, Reid DG, Schoppet M, Shanahan CM, Skepper JN, Wise ER: Mineral surface in calcified plaque is like that of bone: Further evidence for regulated mineralization. Arterioscler Thromb Vasc Biol 28:2030-2034, 2008
30. Ewence AE, Bootman M, Roderick HL, Skepper JN, McCarthy G, Epple M, Neumann M, Shanahan CM, Proudfoot D: Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: A potential mechanism in atherosclerotic plaque destabilization. Circ Res 103:e28-e34, 2008
31. Sage AP, Lu J, Tintut Y, Demer LL: Hyperphosphatemiainduced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 79:414-422, 2011
32. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208-2218, 2004
33. McIntyre CW: Calcium balance during hemodialysis. Semin Dial 21:38-42, 2008
34. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:E10-E17, 2000
35. El-Abbadi MM, Pai AS, Leaf EM, Yang HY, Bartley BA, Quan KK, Ingalls CM, Liao HW, Giachelli CM: Phosphate feeding induces arterial medial calcification in uremic mice: Role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int 75:1297-1307, 2009
36. Fleckenstein-Grün G, Thimm F, Czirfuzs A, Matyas S, Frey M: Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations. J Cardiovasc Pharmacol 24 [Suppl 2]: S75-S84, 1994
37. Ohanian J, Gatfield KM, Ward DT, Ohanian V: Evidence for a functional calcium-sensing receptor that modulates myogenic tone in rat subcutaneous small arteries. Am J Physiol Heart Circ Physiol 288:H1756-H1762, 2005
38. Molostvov G, James S, Fletcher S, Bennett J, Lehnert H, Bland R, Zehnder D: Extracellular calcium-sensing receptor is functionally expressed in human artery. Am J Physiol Renal Physiol 293:F946-F955, 2007
39. Alam MU, Kirton JP, Wilkinson FL, Towers E, Sinha S, Rouhi M, Vizard TN, Sage AP, Martin D, Ward DT, Alexander MY, Riccardi D, Canfield AE: Calcification is associated with loss of functional calciumsensing receptor in vascular smooth muscle cells. Cardiovasc Res 81:260-268, 2009
40. Motro M, Shemesh J: Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension 37:1410-1413, 2001
41. Speer MY, Li X, Hiremath PG, Giachelli CM: Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J Cell Biochem 110:935-947, 2010
42. Jono S, Peinado C, Giachelli CM: Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 275:20197-20203, 2000
43. Pai AS, Giachelli CM: Matrix remodeling in vascular calcification associated with chronic kidney disease. J Am Soc Nephrol 21:1637-1640, 2010
44. Neven E, Dams G, Postnov A, Chen B, De Clerck N, De Broe ME, D'Haese PC, Persy V: Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats. Nephrol Dial Transplant 24:1790-1799, 2009
45. Nakagawa Y, Ikeda K, Akakabe Y, Koide M, Uraoka M, Yutaka KT, Kurimoto-Nakano R, Takahashi T, Matoba S, Yamada H, Okigaki M, Matsubara H: Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo. Arterioscler Thromb Vasc Biol 30:1908-1915, 2010
46. Chen NX, Duan D, O'Neill KD, Wolisi GO, Koczman JJ, Laclair R, Moe SM: The mechanisms of uremic serum-induced expression of bone matrix proteins in bovine vascular smooth muscle cells. Kidney Int 70:1046-1053, 2006
47. Olszak IT, Poznansky MC, Evans RH, Olson D, Kos C, Pollak MR, Brown EM, Scadden DT: Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo. J Clin Invest 105:1299-1305, 2000
48. Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE: Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 44:1024-1030, 2004
49. Spiegel DM, Raggi P, Smits G, Block GA: Factors associated with mortality in patients new to haemodialysis. Nephrol Dial Transplant 22:3568-3572, 2007
50. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P: Effects of sevelamer and calciumon coronary artery calcification in patients new to hemodialysis. Kidney Int 68:1815-1824, 2005
51. Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK: Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19:1489-1496, 2004
52. Moe SM, Reslerova M, Ketteler M, O'neill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX: Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 67:2295-2304, 2005
53. O'Neill WC, Sigrist MK, McIntyre CW: Plasma pyrophosphate and vascular calcification in chronic kidney disease. Nephrol Dial Transplant 25:187-191, 2010
54. Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J, Rees L: The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 23:3263-3271, 2008
55. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 361:827-833, 2003
56. Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, Van Diest R, Appels A, Reutelingsperger CP, Cleutjens JP, Vermeer C: Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: Undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 25:1629-1633, 2005
57. Shanahan CM, Proudfoot D, Farzaneh-Far A, Weissberg PL: The role of Gla proteins in vascular calcification. Crit Rev Eukaryot Gene Expr 8:357-375, 1998
58. Proudfoot D, Skepper JN, Shanahan CM, Weissberg PL: Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol 18:379-388, 1998
59. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K: Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638-647, 2002
60. Rogers NM, Teubner DJ, Coates PT: Calcific uremic arteriolopathy: Advances in pathogenesis and treatment. Semin Dial 20:150-157, 2007
61. Aikawa E, Nahrendorf M, Figueiredo JL, Swirski FK, Shtatland T, Kohler RH, Jaffer FA, Aikawa M, Weissleder R: Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 116:2841-2850, 2007
62. Al-Aly Z, Shao JS, Lai CF, Huang E, Cai J, Behrmann A, Cheng SL, Towler DA: Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/-mice. Arterioscler Thromb Vasc Biol 27:2589-2596, 2007
63. Fleckenstein-Grün G, Frey M, Thimm F, Hofgärtner W, Fleckenstein A: Calcium overload - an important cellular mechanism in hypertension and arteriosclerosis. Drugs 44 [Suppl 1]: 23-30, 1992
64. Kovacic JC, Moreno P, Nabel EG, Hachinski V, Fuster V: Cellular senescence, vascular disease, and aging: Part 2 of a 2-part review: Clinical vascular disease in the elderly. Circulation 123:1900-1910, 2011
65. Razzaque MS, Sitara D, Taguchi T, St-Arnaud R, Lanske B: Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 20:720-722, 2006
66. Kuro O: Phosphate and Klotho. Kidney Int Suppl 79 [Suppl 121]: S20-S23, 2011
67. Hu MC, Shi M, Zhang J, Quiñones H, Griffith C, Kuro-o M, Moe OW: Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22:124-136, 2011
68. Takemura A, Iijima K, Ota H, Son BK, Ito Y, Ogawa S, Eto M, Akishita M, Ouchi Y: Sirtuin 1 retards hyperphosphatemia-induced calcification of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 31:2054-2062, 2011
69. Burton DG, Giles PJ, Sheerin AN, Smith SK, Lawton JJ, Ostler EL, Rhys-Williams W, Kipling D, Faragher RG: Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification. Exp Gerontol 44:659-665, 2009
70. Nakano-Kurimoto R, Ikeda K, Uraoka M, Nakagawa Y, Yutaka K, Koide M, Takahashi T, Matoba S, Yamada H, Okigaki M, Matsubara H: Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. Am J Physiol Heart Circ Physiol 297:H1673-H1684, 2009
71. Holick MF: Vitamin D deficiency. N Engl J Med 357:266-281, 2007
72. Shalhoub V, Shatzen E, Henley C, Boedigheimer M, McNinch J, Manoukian R, Damore M, Fitzpatrick D, Haas K, Twomey B, Kiaei P, Ward S, Lacey DL, Martin D: Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols. Calcif Tissue Int 79:431-442, 2006
73. Wu-Wong JR, Noonan W, Ma J, Dixon D, Nakane M, Bolin AL, Koch KA, Postl S, Morgan SJ, Reinhart GA: Role of phosphorus and vitaminD analogs in the pathogenesis of vascular calcification. J Pharmacol Exp Ther 318:90-98, 2006
74. Zebger-Gong H, Müller D, Diercke M, Haffner D, Hocher B, Verberckmoes S, Schmidt S, D'Haese PC, Querfeld U: 1, 25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: Up-regulation of osteoblast markers, calcium-transporting proteins and osterix. J Hypertens 29:339-348, 2011
75. Rebsamen MC, Sun J, Norman AW, Liao JK: 1alpha, 25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 91:17-24, 2002
76. Becker LE, Koleganova N, Piecha G, Noronha IL, Zeier M, Geldyyev A, Kökeny G, Ritz E, Gross ML: Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice. Am J Physiol Renal Physiol 300:F772-F782, 2011
77. Kuro-o M: Overview of the FGF23-Klotho axis. Pediatr Nephrol 25:583-590, 2010
78. Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA: Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 19:1509-1519, 2008
79. Mizobuchi M, Finch JL, Martin DR, Slatopolsky E: Differential effects of vitaminD receptor activators on vascular calcification in uremic rats. Kidney Int 72:709-715, 2007
80. London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F: Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18:613-620, 2007
81. Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, Hiorns MP, Deanfield JE, Rees L: A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 19:1239-1246, 2008
82. Fliser D: Perspectives in renal disease progression: The endothelium as a treatment target in chronic kidney disease. J Nephrol 23:369-376, 2010
83. Kanno Y, Into T, Lowenstein CJ, Matsushita K: Nitric oxide regulates vascular calcification by interfering with TGF-signalling. Cardiovasc Res 77:221-230, 2008
84. Dao HH, Essalihi R, Graillon JF, Larivière R, De Champlain J, Moreau P: Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension. JHypertens 20:1597-1606, 2002
85. Wu SY, Zhang BH, Pan CS, Jiang HF, Pang YZ, Tang CS, Qi YF: Endothelin-1 is a potent regulator in vivo in vascular calcification and in vitro in calcification of vascular smooth muscle cells. Peptides 24:1149-1156, 2003
86. Long DA, Norman JT, Fine LG: Restoring the renal microvasculature to treat chronic kidney disease. Nat Rev Nephrol 8:244-250, 2012
87. David S, John SG, Jefferies HJ, Sigrist MK, Kümpers P, Kielstein JT, Haller H, McIntyre CW: Angiopoietin-2 levels predict mortality in CKD patients. Nephrol Dial Transplant 27:1867-1872, 2012
88. Jeong BC, Kim HJ, Bae IH, Lee KN, Lee KY, Oh WM, Kim SH, Kang IC, Lee SE, Koh GY, Kim KK, Koh JT: COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation. Bone 46:479-486, 2010
89. Maes C, Carmeliet P, Moermans K, Stockmans I, Smets N, Collen D, Bouillon R, Carmeliet G: Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 111:61-73, 2002
90. Mikhaylova L, Malmquist J, Nurminskaya M: Regulation of in vitro vascular calcification by BMP4, VEGF and Wnt3a. Calcif Tissue Int 81:372-381, 2007
91. Couper LL, Bryant SR, Eldrup-Jørgensen J, Bredenberg CE, Lindner V: Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1. Circ Res 81:932-939, 1997
92. Tian S, Hayes AJ, Metheny-Barlow LJ, Li LY: Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1. Br J Cancer 86:645-651, 2002
93. Litwin M, Wühl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Tröger J, Mehls O, Schaefer F: Alteredmorphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494-1500, 2005
94. Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, Ellins EA, Storry C, Ridout D, Deanfield J, Rees L: Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 618:2996-3003, 2007
95. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK: Association of elevated serum PO (4), Ca x PO (4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131-2138, 2001
96. Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, Ling BN, Chasan-Taber S, Dillon MA, Blair AT, Burke SK: Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 72:1130-1137, 2007
97. Isakova T, Gutiérrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M: Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20:388-396, 2009
98. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of timevarying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771-780, 2006
99. Chertow GM, Burke SK, Raggi P; Treat to Goal Working Group: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252, 2002
100. Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, Budoff M; CARE-2 Investigators: A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis 51:952-965, 2008
101. Sigrist M, McIntyre CW: Calcium exposure and removal in chronic hemodialysis patients. J Ren Nutr 16:41-46, 2006
102. Bushinsky DA: Contribution of intestine, bone, kidney, and dialysis to extracellular fluid calcium content. Clin J Am Soc Nephrol 5 [Suppl 1]: S12-S22, 2010
103. London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, De Vernejoul MC: Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19:1827-1835, 2008
104. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113:S1-S130, 2009
105. Bellasi A, Kooienga L, Block GA, Veledar E, Spiegel DM, Raggi P: How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis? J Nephrol 22:255-262, 2009
106. Pauly RP, Gill JS, Rose CL, Asad RA, Chery A, Pierratos A, Chan CT: Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant 24:2915-2919, 2009
107. Chan CT, Lovren F, Pan Y, Verma S: Nocturnal haemodialysis is associated with improved vascularsmoothmuscle cell biology. Nephrol Dial Transplant 24:3867-3871, 2009
108. De Lima JJ, Vieira ML, Viviani LF, Medeiros CJ, Ianhez LE, Kopel L, De Andrade JL, Krieger EM, Lage SG: Longterm impact of renal transplantation on carotid artery properties and on ventricular hypertrophy in end-stage renal failure patients. Nephrol Dial Transplant 17:645-651, 2002
109. Litwin M, Wühl E, Jourdan C, Niemirska A, Schenk JP, Jobs K, Grenda R, Wawer ZT, Rajszys P, Mehls O, Schaefer F: Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant 23:2552-2557, 2008
110. McIntyre CW: Is it practical to screen dialysis patients for vascular calcification? Nephrol Dial Transplant 21:251-254, 2006